Bruker Corporation reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company’s revenue was $393.4 million compared to $405.6 million a year ago. Operating income was $12.2 million compared to $34.4 million a year ago. Income before income taxes and non-controlling interest in consolidated subsidiaries was $8.3 million compared to $26.9 million a year ago. Net income attributable to the company was $5.4 million or $0.03 per basic and diluted share compared to $15.1 million or $0.09 per basic and diluted share a year ago. On adjusted basis, operating income was $23.6 million compared to $43.6 million a year ago. Non-GAAP net income attributable to the company was $13.4 million or $0.08 per basic and diluted share compared to $23.8 million or $0.14 per basic and diluted share a year ago. Non-GAAP operating income was $23.6 million against $43.6 million for the same period a year ago. Non-GAAP profit before tax was $18.8 million against $36.1 million for the same period a year ago. Net cash used in operating activities was $18.2 million compared to net cash provided by operating activities of $4.8 million a year ago. Purchases of property, plant and equipment was $14.6 million compared to $11.6 million a year ago. The company expects to see a reduction of reported revenue growth rates by approximately 2% due to the recent Yen depreciation. This reduction is expected to result in reported revenue growth of 2% to 3% for the full year 2013. The company now expects to report full year 2013 non-GAAP EPS of between $0.80 and $0.83, a reduction of $0.08 from previous guidance, also due primarily to the weaker Yen. The company expects non-GAAP tax rate to be between 27% to 30%.

Bruker Corporation Expands Capabilities of MALDI Biotyper Platform for Microbiology. The MALDI Biotyper (MBT) is the market-leading system for microbial identification based on MALDI-TOF mass spectrometry. It is widely used in clinical microbiology, industrial microbiology, animal health and food safety and has become the broadly accepted laboratory standard for next generation microbial identification. While conventional biochemical testing takes time-consuming incubation after selection of the microbes from the culture plate, the MALDI Biotyper allows for an instantaneous identification of colonies from a plate. The MALDI Biotyper system covers a broad range of more than 4,600 microbial isolates from gram-negative bacteria, gram-positive bacteria, yeasts, multicellular fungi and mycobacteria. It is broadly applicable as a standard identification tool in various fields of microbiology. Microbial identification with the MALDI Biotyper is done using a proteomic fingerprint. This unique species-specific pattern is automatically compared with reference spectra in the MALDI Biotyper library. In addition, the MALDI Biotyper supports the Open Microbiology Concept which allows customers to generate their own database entries from regional isolates via a push-button storage in a customer-specific sub-library. The new second edition of the MBT Mycobacteria Library adds another 140 isolates from 37 new species. The library is fully compatible with all standard cultivation media for mycobacteria, such as solid Löwenstein-Jensen medium or in liquid culture using the MGIT(TM) system from Becton Dickinson. With these added capabilities the MALDI Biotyper covers now more than 130 species of mycobacteria. The new MALDI Biotyper Pilot(TM) accessory complements the satellite software to a complete, barcoded and paperless workflow. The MBT Pilot is used for light-guided manual target preparation using cross hairs to indicate the next position for preparation on the MALDI target. Barcoding of the MALDI target and the sample, along with multiple isolate support, ensure that the complete process is fully traceable. The new MALDI Biotyper Galaxy(TM) performs a quality-controlled automated deposition of the MALDI matrix onto the target plate. After the preparation it scans the target positions and checks if each spot is optimally prepared for MALDI Biotyper measurements. The MBT Galaxy has a seamless integration into the MBT server coupled with on-board barcode reading and automated loading of the associated project work list. Both MBT Pilot and MBT Galaxy are scheduled to be commercially available in 2013. The revolutionary MALDI-Biotyper-Spectrum-Beta-Lactamase(TM) workflow (MSBL(TM)) enables users to perform patented functional beta-lactam antibiotic resistance testing for selected antibiotics on the MALDI Biotyper platform. The cleavage of beta-lactam antibiotics, like penicillins, 3(rd) generation cephalosporins or carbapenems by resistant bacteria leads to specific mass shifts of the cleaved products. Such mass shifts can be observed and monitored using the MALDI Biotyper, and automatically interpreted with the MSBL software module, which is also expected to be commercially availability later 2013.

Bruker Corporation announced the second release of its successful NMR WineScreener. With this new release more than 110 parameters can be evaluated under push button automation, with targeted analysis of more than 50 quantification parameters, and up to 60 statistical parameters, covering properties such as geographical origin, grape variety and vintage year. With this further increase in the already large number of analytical parameters obtained in a single NMR measurement, the NMR WineScreener 2.0 offers low costs per sample and even lower costs per individual parameter. The WineScreener analysis is built on more than 5,000 wines that have been measured over the last 15 month. For every compound measured, quantified variety-specific concentration distribution curves are available, providing additional quality parameters beyond the OIV defined thresholds. The revolutionary performance of the NMR WineScreener 2.0 has convinced Intervitis/Interfructa officials to award a 2013 innovation prize to this unique wine-analysis system. Worldwide grape variety models for red and white wines form the basis of the statistical analysis, supplemented by origin and vintage models that provide valuable analysis tools for the authentication of wine.